EP3851105
MIGALASTAT FOR USE IN TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENE
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
7.8.2020EP published:
4.3.2026EP application number:
20190096.6
EPO information:
European Patent Register
Max expiry date:
6.8.2040Expiry date:
6.8.2026
Title in English:
MIGALASTAT FOR USE IN TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENELanguage of the patent:
English
Timeline
Today
7.8.2020EP application
4.3.2026EP Publication
6.8.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
BENJAMIN, ElfridaAddress:
Cranbury, NJ New Jersey 08512, US
Name:
WU, XiaoyangAddress:
Cranbury, NJ New Jersey 08512, US
Priority
Number:
201962883756 PDate:
7.8.2019Country:
US
Number:
202062986297 PDate:
6.3.2020Country:
US
Classification
Categories:
A61K 31/445, A61P 3/00